GENZ touches 200-day moving average at 74.19 -
GENZ touches 50-day moving average at 79.33 -
UPDATE 1-Genzyme sees US FDA action on Myozyme by late Nov -
Genzyme Corp inaugurates new USD125m Science Center in Framingham, Mass -
Genzyme Hits Lowest Level In Over 2 Weeks -
GENZ touches 50-day moving average at 78.20 -
Genzyme Dips Below 50-Day Moving Average -
Genzyme Corp. Is Losing Ground After The Bell -
BRIEF: Genzyme in charitable partnership to end malaria -
GENZ: To Present At IBC Life Sciences DDT 2008 Conference @ 09:50 ET [delayed] -
Genzyme Shares Sink On More Production Delays For Genetic Disorder Drug Myozyme -
Genzyme Declines On Lower Q2 Profit -
Genzyme (GENZ) NewsBite - Genzyme 2Q Profit Falls on Charges -